drugset / Trial / NCT02214953
Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To compare the oral bioavailability and rate of absorption of four prototype extended-release (ER) formulations with BI 11634 (single doses) to immediate-release (IR) tablets in healthy male volunteers.
Timeline
- Start
- 2007-10
- Primary completion
- 2007-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 11634 | Unknown | 25 mg | — |
Indications
No indication recorded.